Literature DB >> 17545691

Clinical implications of founder and recurrent CDH1 mutations in hereditary diffuse gastric cancer.

Kirsten N Kangelaris, Stephen B Gruber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17545691     DOI： 10.1001/jama.297.21.2410

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population.

Authors:  Zhen Zhan; Juan Wu; Jun-Feng Zhang; Ya-Ping Yang; Shujuan Tong; Chun-Bing Zhang; Jin Li; Xue-Wen Yang; Wei Dong
Journal:  Mol Biol Rep       Date:  2012-04-26       Impact factor: 2.316

2.  Higher risk of progressing breast cancer in Kurdish population associated to CDH1 -160 C/A polymorphism.

Authors:  Farzaneh Zarei; Mohammad Nazir Menbari; Bayazid Ghaderi; Mohammad Abdi; Zakaria Vahabzadeh
Journal:  EXCLI J       Date:  2017-11-06       Impact factor: 4.068

Review 3.  Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms.

Authors:  Zeinab Safarpour Lima; Mostafa Ghadamzadeh; Farzad Tahmasebi Arashloo; Ghazaleh Amjad; Mohammad Reza Ebadi; Ladan Younesi
Journal:  J Hematol Oncol       Date:  2019-04-11       Impact factor: 17.388

4.  Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients.

Authors:  Hidetaka Yamada; Kazuya Shinmura; Masanori Goto; Moriya Iwaizumi; Hiroyuki Konno; Hideki Kataoka; Masami Yamada; Takachika Ozawa; Toshihiro Tsuneyoshi; Fumihiko Tanioka; Haruhiko Sugimura
Journal:  Mol Cancer       Date:  2009-08-12       Impact factor: 27.401

5.  A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.

Authors:  Eliseos J Mucaki; Natasha G Caminsky; Ami M Perri; Ruipeng Lu; Alain Laederach; Matthew Halvorsen; Joan H M Knoll; Peter K Rogan
Journal:  BMC Med Genomics       Date:  2016-04-11       Impact factor: 3.063

6.  The CDH1 -160C/A polymorphism is associated with breast cancer: evidence from a meta-analysis.

Authors:  Ying-Yu Ma; Wei-Quan Wu; Zheng-Chuang Liu; Xiao-Fen Yu; Kun Guo; Qi-Wen He; Shi-Bin Jiang; Qin-Shu Shao; Hou-Quan Tao; Dong-Sheng Huang
Journal:  World J Surg Oncol       Date:  2016-06-27       Impact factor: 2.754
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.